Filing Details

Accession Number:
0001209191-13-022520
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2013-04-25 16:46:50
Reporting Period:
2013-04-12
Filing Date:
2013-04-25
Accepted Time:
2013-04-25 16:46:50
Original Submission Date:
2013-04-16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131096 Athenahealth Inc ATHN Services-Business Services, Nec (7389) 043387530
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204310 N Stephen Kahane 311 Arsenal Street
Watertown MA 02472
President, Enterprise Services No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-12 4,500 $45.10 114,520 No 4 M Direct
Common Stock Acquisiton 2013-04-12 2,560 $45.10 117,080 No 4 M Direct
Common Stock Disposition 2013-04-12 14,035 $94.57 103,045 No 4 S Direct
Common Stock Disposition 2013-04-12 3,158 $95.34 99,887 No 4 S Direct
Common Stock Disposition 2013-04-16 9,125 $95.10 90,762 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-04-12 4,500 $0.00 4,500 $45.10
Common Stock Stock Option (Right to Buy) Disposition 2013-04-12 2,560 $0.00 2,560 $45.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,000 2012-03-01 2021-03-01 No 4 M Direct
15,561 2013-03-01 2021-03-01 No 4 M Direct
Footnotes
  1. Includes 163 shares purchased pursuant to the Issuer's 2007 Employee Stock Purchase Plan on March 31, 2013, which transaction is considered exempt pursuant to Rule 16b-3(c) promulgated under the Securities Exchange Act of 1934.
  2. The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on February 12, 2013, in accordance with Rule 10b5-1.
  3. This price represents the weighted average of sales ranging from $94.11 to $95.10. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  4. This price represents the weighted average of sales ranging from $95.13 to $95.83. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.